Skip to main content
. Author manuscript; available in PMC: 2014 May 13.
Published in final edited form as: Health Phys. 2008 Jul;95(1):119–147. doi: 10.1097/01.HP.0000291191.49583.f7

Table 3.

Summary of probability distributions of radiation effectiveness factors (REFs) for neutrons and alpha particles in IRERa

Neutrons and solid cancerb 95% credibility interval of REFHc
Energy Exposure 2.5th percentile 50th percentile 97.5th percentile
0.1–2 MeV Acute 2.0   7.7 30
Chronic 2.4 10 47
10–100 keV; 2–20 MeV Acute 1.2   3.8 18
Chronic 1.4   4.7 28
<10keV; >20 MeV Acute 1.1   1.9 11
Chronic 1.1   2.4 16

Neutrons and leukemiab 95% credibility interval of REFLd
Energy Exposure 2.5th percentile 50th percemile 97.5th percentile

0.1–2 MeV Acute 2.0 11 60
Chronic 2.5 14 91
10–100 keV; 2–20 MeV Acute 1.3   5.6 36
Chronic 1.5   7.1 55
<10 keV; >20 MeV Acute 1.1   2.8 22
Chronic 12   3.4 34

Alpha particlese 95% credibility interval of REFLd
Cancer type Exposure 2.5th perrentile 50th percentib 97.5th percentile

Solid cancers All 3.4 18 100
Leukemia All 1.0   4.1   42
a

Adapted from Table 14 of Kocher et aL (2005). Many probability distributions are not described by commonly used continuous distributions (e.g., lognormal).

b

Probability distributions are described in Table 5 of Kocher et al. (2005): distributions under conditions of chronic exposure include enhancement factor to represent inverse dose-rate effect.

c

REFH is REF at high doses and high dose rates of reference high-energy (>250 keV) photons.

d

REFL is REF at low doses and low dose rates of reference high-energy (>25Q keV) photons.

e

Probability distributions are described in Table 7 of Kocher et al. (2005) and apply to alpha particles of any energy produced in radioactive decay; all distributions include enhancement factor to represent inverse dose-rate effect.